- J. Thomas Parmeter, Ph.D. Chairman
of the Board of Directors, President and CEO
- Mr. Parmeter has been the Company's President, Chief
Executive Officer and Chairman of the Board of Directors since its inception
in July 1988. From 1982 to November 1987, Mr. Parmeter was President,
Chief Executive Officer and, from June 1987 to June 1988, Chairman of
the Board of Syntro Corporation.
- Joseph Cappello, Ph.D. Vice President,
Research and Development; CTO and Director, Polymer Research
- Dr. Cappello has been the Company's Vice President,
Research and Development, since February 1997 and Director, Polymer
Research, and Chief Technical Officer since February 1993. From September
1988 to February 1993, he was the Company's Senior Research Director,
Protein Engineering.
- Philip J. Davis Corporate Secretary
- Mr. Davis has been the Company's Secretary since January
1989. Mr. Davis has been a director of the Company since April 1995;
he previously served as a director of the Company from January 1989
until October 1991. Mr. Davis has been a Senior Vice President with
Donaldson, Lufkin & Jenrette since March 1995. He was Director,
Institutional Sales, at Merrill Lynch, Inc. (formerly Merrill Lynch
Capital Markets), from February 1991 to March 1995, and was a Vice President
at Merrill Lynch, Inc., from 1986 to 1995.
- Franco A. Ferrari, Ph.D. Vice President,
Laboratory Operations and Polymer Production, and Director, Molecular
Genetics
- Dr. Ferrari has been the Company's Vice President,
Laboratory Operations, and Director, Molecular Genetics, since February
1993. From September 1988 to February 1993, he was the Company's Senior
Research Director, Genetic Engineering.
- John E. Flowers Vice President, Planning and
Operations
- Mr. Flowers has been the Company's Vice President,
Planning and Operations, since February 1993. From September 1988 to
February 1993, he was the Company's Vice President, Commercial Development.
- Janis Y. Neves Controller and Assistant Secretary
- Ms. Neves has been the Company's Controller and Assistant
Secretary since January 1990. From July 1988 until January 1990, Ms.
Neves was the Company's Business Office Manager.
- Erwin R. Stedronsky, Ph.D. Vice President,
Product Formulation and Engineering, and Director, Materials Science
- Dr. Stedronsky has been the Company's Vice President,
Product Formulation and Engineering, since February 1997 and Director
of Materials Science since September 1992. For approximately 20 years
prior to joining PPTI, Dr. Stedronsky held increasingly responsible
R&D positions in Corporate Research at Monsanto Company.
- Aron P. Stern Vice President, Finance and
Administration, and CFO
- Mr. Stern has been the Company's Vice President, Finance
and Administration, and Chief Financial Officer since July 1992. Previously
Mr. Stern served as Director, Finance and Administration, of Isis Pharmaceuticals,
Inc., from May 1989 to June 1992.
- Jane Willoughby, Ph.D. Director, Business
Development
- Dr. Willoughby has been the Company's Director of
Business Development since April 1997. Dr. Willoughby was previously
employed by Smith & Nephew as the General Manager and Project Consultant
for the Advanced Tissue Sciences-Smith and Nephew joint venture set
up to develop tissue engineered cartilage implants (1994-1996). Prior
to that, Dr. Willoughby held the position of Head of Biological Sciences
at the central research facility for Smith & Nephew plc in York, England
(1991-1994).
|
